Low CD4 count and educational status predict abnormal cervical smears amongst HIV-positive women initiating antiretroviral therapy in South Africa

Low CD4 count and educational status predict abnormal cervical smears amongst HIV-positive women initiating antiretroviral therapy in South Africa

Cervical cancer is common amongst human immunodeficiency virus (HIV)-positive women in low- and middle-income countries. In South Africa, more than 7500 cases are diagnosed annually and over 50% result in death, making cervical cancer the leading cause of cancer mortality.1 South Africa’s high HIV...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Mthembu, N, Dorward, J, Naicker, N, Osman, F, Gumede, S, Sookrajh, Y, Drain, P, Garrett, N
Natura:	Journal article
Pubblicazione:	AOSIS 2020

Documenti analoghi

Low CD4 count and educational status predict abnormal cervical smears amongst HIV-positive women initiating antiretroviral therapy in South Africa
di: Nondumiso Mthembu, et al.
Pubblicazione: (2020-03-01)

Early antiretroviral therapy is associated with better viral suppression and less HIV drug resistance after implementation of universal treatment in South Africa
di: Dorward, J, et al.
Pubblicazione: (2019)

Diagnostic accuracy of the Alere Afinion AS100 point-of-care assay to screen for non-communicable diseases amongst people living with HIV
di: Bodley, N, et al.
Pubblicazione: (2022)

HIV treatment outcomes among people with initiation CD4 counts >500 cells/µL after implementation of Treat All in South African public clinics: a retrospective cohort study
di: Dorward, J, et al.
Pubblicazione: (2020)

Delivery of community-based antiretroviral therapy to maintain viral suppression and retention in care in South Africa
di: Wang, M, et al.
Pubblicazione: (2023)

Viremia and HIV drug resistance among people receiving dolutegravir versus efavirenz-based first-line antiretroviral therapy
di: Dorward, J, et al.
Pubblicazione: (2024)

High burden of human papillomavirus and premalignant cervical lesions among women starting HIV treatment in KwaZulu-Natal, South Africa
di: Naicker, N, et al.
Pubblicazione: (2024)

Urine tenofovir and dried blood spot tenofovir diphosphate concentrations and viraemia in people taking efavirenz and dolutegravir based antiretroviral therapy
di: Dorward, J, et al.
Pubblicazione: (2023)

Detection of abnormal cervical cytology in Papanicolaou smears
di: Manjit Singh Bal, et al.
Pubblicazione: (2012-01-01)

Detection of Abnormal Cervical Cytology by Pap Smears
di: Sania Tanveer Khattak, et al.
Pubblicazione: (2004-06-01)

Diagnostic accuracy of a point-of-care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz-based antiretroviral therapy
di: Dorward, J, et al.
Pubblicazione: (2023)

Spectrum of Abnormal Cervical Cytology in Papanicolaou (PAP) Smears
di: Ghazala Mudassir, et al.
Pubblicazione: (2018-03-01)

Empiric deworming and CD4 count recovery in HIV-infected Ugandans initiating antiretroviral therapy.
di: Alexander J Lankowski, et al.
Pubblicazione: (2014-08-01)

Prevalence of abnormal cervical smears among females in Kirkuk governorate
di: Khalida Mohammed, et al.
Pubblicazione: (2012-12-01)

Cytologic abnormalities noted in the cervical smears of high-risk persons
di: S P Somashekhar, et al.
Pubblicazione: (2021-01-01)

Conceptualising implementation strategies in HIV research – Authors' reply
di: Drain, PK, et al.
Pubblicazione: (2020)

Point-of-care viral load testing and differentiated HIV care
di: Dorward, J, et al.
Pubblicazione: (2017)

Absolute Lymphocyte Count Is Not a Suitable Alternative to CD4 Count for Determining Initiation of Antiretroviral Therapy in Fiji
di: Dashika A. Balak, et al.
Pubblicazione: (2014-01-01)

Diagnostic accuracy of the rapid Xpert HIV-1 Viral Load XC, Xpert HIV-1 Viral Load & m-PIMA HIV-1/2 Viral Load in South African clinics
di: Dorward, J, et al.
Pubblicazione: (2022)

Human herpesvirus replication and abnormal CD8+ T cell activation and low CD4+ T cell counts in antiretroviral-suppressed HIV-infected patients.
di: Mark A Jacobson, et al.
Pubblicazione: (2009-01-01)

Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries: uncertainties and opportunities for implementation and research
di: Dorward, J, et al.
Pubblicazione: (2018)

Clinic flow for STI, HIV, and TB patients in an urban infectious disease clinic offering point-of-care testing services in Durban, South Africa
di: Stime, K, et al.
Pubblicazione: (2018)

Comparing absolute lymphocyte count to total lymphocyte count, as a CD4 T cell surrogate, to initiate antiretroviral therapy
di: Srirangaraj Sreenivasan, et al.
Pubblicazione: (2011-01-01)

Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-term T-cell reconstitution.
di: Lewis, J, et al.
Pubblicazione: (2012)

Absolute lymphocyte count as a marker for CD4 lymphocyte count: criterion for initiating antiretroviral therapy in HIV-infected Nigerians
di: Adias Teddy C, et al.
Pubblicazione: (2009-09-01)

Differentiated service delivery for people using second-line antiretroviral therapy: clinical outcomes from a retrospective cohort study in KwaZulu-Natal, South Africa
di: Lewis, L, et al.
Pubblicazione: (2021)

World Health Organisation staging, adherence to HAART and abnormal cervical smears amongst HIV-infected women attending a government hospital in Johannesburg, South Africa
di: Appolinaire C. Katumba, et al.
Pubblicazione: (2016-12-01)

The agreement between self-reported cervical smear abnormalities and screening programme records.
di: Canfell, K, et al.
Pubblicazione: (2006)

Detection of Abnormal Cervical Cytology in Papanicolaou Smears in a Tertiary Care Center
di: Suspana Hirachand, et al.
Pubblicazione: (2013-07-01)

Detection of Abnormal Cervical Cytology in Papanicolaou Smears in a Tertiary Care Center
di: Suspana Hirachand, et al.
Pubblicazione: (2013-07-01)

COMPARISON OF CONVENTIONAL PAP SMEAR AND LIQUID-BASED CYTOLOGY IN DETECTING CERVICAL ABNORMALITIES
di: Secerovic Djelila
Pubblicazione: (2024-08-01)

Abnormal Pap smear among pregnant women – Feasibility of opportunistic cervical screening
di: Nur Farihan Mukhtar, et al.
Pubblicazione: (2023-09-01)

Analysis of abnormal epithelial lesions in cervical Pap smears in Mid-Western Nepal
di: SK Ranabhat, et al.
Pubblicazione: (2011-03-01)

Diagnostic accuracy of a point‐of‐care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz‐based antiretroviral therapy
di: Jienchi Dorward, et al.
Pubblicazione: (2023-09-01)

CD4+ cell count recovery following initiation of HIV antiretroviral therapy in older childhood and adolescence
di: Simms, V, et al.
Pubblicazione: (2018)

World Health Organization guidelines should not change the CD4 count threshold for antiretroviral therapy initiation
di: Nathan Geffen
Pubblicazione: (2013-02-01)

CD4+ cell count recovery after initiation of antiretroviral therapy in HIV-infected Ethiopian adults.
di: Temesgen Fiseha, et al.
Pubblicazione: (2022-01-01)

Intimate Partner Violence and HIV Outcomes Among Women Living with HIV in Durban, South Africa
di: Ojeaburu, SO, et al.
Pubblicazione: (2024)

FREQUENCY OF ABNORMAL PAP SMEAR AND ASSESSMENT OF RISK FACTORS FOR CERVICAL CANCER IN AN OUTPATIENT CLINIC
di: Firdous Jahan, et al.
Pubblicazione: (2008-07-01)

FREQUENCY OF ABNORMAL PAP SMEAR AND ASSESSMENT OF RISK FACTORS FOR CERVICAL CANCER IN AN OUTPATIENT CLINIC
di: Firdous Jahan, et al.
Pubblicazione: (2008-07-01)